ABI
Adamant Biomedical Investments Portfolio holdings
AUM
$418M
1 Year Est. Return
–
AUM
$418M
AUM Growth
+$17.7M
(+4.4%)
Holding
108
Top Buys
| 1 | +$5.51M | |
| 2 | +$5.4M | |
| 3 | +$4.71M | |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
+$4.48M |
| 5 |
Ligand Pharmaceuticals
LGND
|
+$4.33M |
Top Sells
| 1 | +$5.12M | |
| 2 | +$4.39M | |
| 3 | +$4.03M | |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$3.82M |
| 5 |
QGENF
QIAGEN NV
QGENF
|
+$3.53M |
Sector Composition
| 1 | Healthcare | 87.28% |
| 2 | Financials | 0.93% |
| 3 | Industrials | 0.35% |
| 4 | Technology | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Insulet
PODD
$21.6B
| – | – |
-80,000
|
|
||
102
Direxion Daily Small Cap Bull 3x Shares
TNA
$1.97B
| – | – |
-60,000
|
|
||
|
VIVS
103
VivoSim Labs
VIVS
$5.74M
| – | – |
-208
|
|
||
|
RVNC
104
DELISTED
Revance Therapeutics, Inc.
RVNC
| – | – |
-130,000
|
|
||
|
WMGI
105
DELISTED
Wright Medical Group Inc
WMGI
| – | – |
-38,000
|
|
||
|
LDRH
106
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| – | – |
-33,000
|
|
||
|
DNDN
107
DELISTED
DENDREON CORPORATION
DNDN
| – | – |
-50,000
|
|